Search

Your search keyword '"Golia, B."' showing total 65 results

Search Constraints

Start Over You searched for: Author "Golia, B." Remove constraint Author: "Golia, B."
65 results on '"Golia, B."'

Search Results

1. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study

2. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: insights from the START Study

4. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

5. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

6. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

7. Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study

8. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

9. Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study

10. Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry

11. Effect of heavy metal stress in Leptodictyum riparium Hedw

15. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury

16. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design

21. Antioxidant activity in extracts from Leptodictyum riparium (Bryophyta), stressed by heavy metals, heat shock, and salinity.

22. Cystatin C and contrast-induced acute kidney injury.

24. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

26. RenalGuard system in high-risk patients for contrast-induced acute kidney injury

27. Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury

28. Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury

29. Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients

30. Antioxidant activity in extracts from Leptodyctium riparium (Bryophyta), stressed by heavy metals, heat shock, salinity

31. Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases.

32. ATM induces MacroD2 nuclear export upon DNA damage.

33. RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation.

34. Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.

35. Poly-ADP-ribosylation signaling during DNA damage repair.

37. Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: randomised comparison of bivalirudin versus unfractionated heparin in patients at high risk of bleeding undergoing elective coronary stenting throught the femoral approach. rationale and design.

38. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.

39. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.

40. Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients.

41. Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention.

42. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.

43. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity.

44. Acetylcysteine and contrast agent-associated nephrotoxicity.

45. Abnormal recovery systolic blood pressure response for detecting coronary artery disease in men and women investigated by upright bicycle exercise.

47. [Electrocardiographic findings in a school-age population using a computerized system: calculation of standard norms for heart rate and PR, QRS, and QT intervals].

48. [Ventricular tachycardia].

50. Non-invasive electrophysiological evaluation of calcium antagonist long-term therapy.

Catalog

Books, media, physical & digital resources